Kepler Capital Markets Reiterates “CHF 235” Price Target for Roche Holding Ltd. (VTX:ROG)
Kepler Capital Markets set a CHF 235 price target on Roche Holding Ltd. (VTX:ROG) in a research report released on Tuesday, July 11th. The brokerage currently has a neutral rating on the healthcare company’s stock.
Several other brokerages have also weighed in on ROG. Goldman Sachs Group Inc set a CHF 335 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Tuesday, June 6th. Jefferies Group LLC set a CHF 305 price target on shares of Roche Holding and gave the company a buy rating in a research report on Monday, May 29th. Morgan Stanley set a CHF 290 price target on shares of Roche Holding and gave the company a buy rating in a research report on Monday, May 29th. J P Morgan Chase & Co reissued a buy rating on shares of Roche Holding in a research report on Saturday, May 20th. Finally, Barclays PLC set a CHF 320 price target on shares of Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of CHF 271.08.
Roche Holding (ROG) traded up 0.45% during midday trading on Tuesday, hitting CHK 248.00. 1,146,799 shares of the stock traded hands. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The firm has a market cap of CHK 211.61 billion and a P/E ratio of 20.95. The company has a 50-day moving average price of CHK 246.61 and a 200-day moving average price of CHK 251.27.
WARNING: “Kepler Capital Markets Reiterates “CHF 235” Price Target for Roche Holding Ltd. (VTX:ROG)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/08/07/roche-holding-ltd-vtxrog-given-a-chf-235-price-target-at-kepler-capital-markets-updated-updated-updated.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.